Matthias H Tschöp Selected Research

Dimethylphenylpiperazinium Iodide

1/2020	Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity.
10/2018	Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias H Tschöp Research Topics

Disease

97	Obesity 01/2022 - 01/2003
77	Body Weight (Weight, Body) 01/2021 - 08/2003
31	Insulin Resistance 11/2020 - 10/2003
24	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2003
24	Weight Loss (Weight Reduction) 03/2019 - 08/2007
16	Glucose Intolerance 10/2018 - 11/2007
15	Inflammation (Inflammations) 01/2021 - 10/2007
10	Hyperphagia (Overeating) 01/2017 - 04/2006
9	AIDS-Related Complex (ARC) 11/2022 - 06/2008
9	Hyperglycemia 10/2018 - 05/2010
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2017 - 10/2007
8	Metabolic Diseases (Metabolic Disease) 10/2021 - 12/2010
7	Dyslipidemias (Dyslipidemia) 01/2020 - 05/2009
6	Weight Gain 01/2019 - 08/2007
5	Neoplasms (Cancer) 01/2018 - 08/2007
5	Cachexia 04/2017 - 07/2008
4	Anorexia 01/2019 - 09/2005
3	Atherosclerosis 01/2021 - 01/2011
3	Non-alcoholic Fatty Liver Disease 01/2021 - 07/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2011
3	Gliosis 02/2018 - 08/2010
3	Anorexia Nervosa 01/2013 - 05/2011
3	Sepsis (Septicemia) 12/2010 - 07/2009
2	Hypoxia (Hypoxemia) 01/2021 - 01/2017
2	Fatty Liver 01/2019 - 10/2016
2	Nausea 01/2019 - 12/2016
2	Ketosis 01/2018 - 01/2011
2	Diabetes Mellitus 01/2018 - 10/2003

Drug/Important Bio-Agent (IBA)

52	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2003
32	GhrelinIBA 01/2018 - 01/2003
25	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 05/2009
20	Peptides (Polypeptides)IBA 01/2021 - 02/2006
20	Insulin (Novolin)FDA Link 01/2020 - 08/2003
18	Hormones (Hormone)IBA 01/2021 - 09/2005
17	LeptinIBA 01/2021 - 04/2006
16	LipidsIBA 01/2020 - 11/2007
11	Pharmaceutical PreparationsIBA 01/2020 - 01/2003
10	Glucagon (Glukagon)FDA Link 01/2020 - 10/2009
9	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021 - 02/2006
9	CarbohydratesIBA 01/2018 - 02/2009
8	Triglycerides (Triacylglycerol)IBA 01/2020 - 03/2008
8	Ghrelin ReceptorsIBA 01/2014 - 03/2008
7	fibroblast growth factor 21IBA 01/2020 - 06/2012
7	CholesterolIBA 01/2020 - 08/2011
5	IncretinsIBA 01/2020 - 10/2013
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2011
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 05/2009
4	MelanocortinsIBA 01/2019 - 11/2007
4	Blood Glucose (Blood Sugar)IBA 01/2018 - 05/2010
4	Glucagon Receptors (Glucagon Receptor)IBA 10/2017 - 10/2009
4	EnzymesIBA 01/2017 - 11/2008
4	salicylhydroxamic acid (SHAM)IBA 12/2016 - 01/2012
4	Estrogens (Estrogen)FDA Link 11/2016 - 08/2008
4	Dietary Fats (Dietary Fat)IBA 04/2014 - 11/2007
4	AcyltransferasesIBA 01/2013 - 05/2011
3	Glial Fibrillary Acidic ProteinIBA 11/2022 - 10/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
3	gastric inhibitory polypeptide receptorIBA 01/2021 - 08/2008
3	Sucrose (Saccharose)IBA 01/2021 - 12/2008
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020 - 10/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 09/2012
3	celastrolIBA 03/2019 - 11/2018
3	Exenatide (Byetta)FDA Link 01/2019 - 06/2012
3	Liraglutide FDA Link 01/2019 - 03/2015
3	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2016
3	Peptide Hormones (Polypeptide Hormones)IBA 01/2018 - 12/2010
3	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2018 - 01/2011
3	GlucocorticoidsIBA 01/2018 - 02/2012
3	RimonabantIBA 12/2015 - 11/2008
3	acyl-ghrelinIBA 01/2014 - 05/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2012 - 11/2009
3	Growth Hormone (Somatotropin)IBA 09/2012 - 02/2009
3	NeuropeptidesIBA 12/2010 - 02/2006
2	Blood Proteins (Serum Proteins)IBA 03/2021 - 01/2021
2	MicellesIBA 03/2021 - 01/2020
2	Dual-Specificity PhosphatasesIBA 11/2020 - 01/2017
2	Uncoupling Protein 1IBA 01/2020 - 01/2020
2	Dimethylphenylpiperazinium IodideIBA 01/2020 - 10/2018
2	Apolipoproteins E (ApoE)IBA 01/2019 - 01/2008
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019 - 02/2012
2	Leptin ReceptorsIBA 01/2019 - 09/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 02/2012
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 06/2007
2	CalcineurinIBA 02/2018 - 11/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 12/2013
2	OsteopontinIBA 01/2018 - 10/2007
2	AcidsIBA 01/2018 - 09/2011
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 10/2017 - 09/2012
2	AntioxidantsIBA 01/2017 - 12/2013
2	setmelanotideIBA 01/2016 - 03/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 01/2012
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2016 - 03/2015
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2015 - 11/2008
2	relamorelinIBA 01/2014 - 07/2008

Therapy/Procedure

20	Therapeutics 01/2022 - 06/2006
7	Bariatric Surgery 01/2019 - 01/2013
5	Drug Therapy (Chemotherapy) 01/2019 - 09/2013
5	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2014 - 08/2007
4	Glycemic Control 01/2019 - 01/2015
3	Caloric Restriction 11/2012 - 08/2007